Concepedia

Astrid Zimmermann

AZ

43

Publications

2.2K

Citations

24

H-Index

1975

Active since

Affiliations

Merck (Germany)(Current)

University of Bern

Ono Pharmaceutical (United States)

Center for Cancer Research

Stanford University

Astrid Zimmermann is an author at Merck (Germany) specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1975–2024

43

Publications

43

Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress

Anish Thomas, Nobuyuki Takahashi, Vinodh N. Rajapakse et al. · Cancer Cell · 2021 · 172 citations · Full text

, , +11

Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells

OK Schlappack, Astrid Zimmermann · British Journal of Cancer · 1991 · 165 citations · Full text

, , +10

The spatial and temporal pattern of beta NGF receptor expression in the developing chick embryo.

Gennadij Raivich, Astrid Zimmermann, Arne Sutter · The EMBO Journal · 1985 · 161 citations · Full text

, , +13

Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models

Frank T. Zenke, Astrid Zimmermann, Christian Sirrenberg et al. · Molecular Cancer Therapeutics · 2020 · 158 citations

beta-Nerve growth factor (beta NGF) receptors on glial cells. Cell-cell interaction between neurones and Schwann cells in cultures of chick sensory ganglia.

Astrid Zimmermann, Arne Sutter · The EMBO Journal · 1983 · 124 citations · Full text

, , +11

Rows per page

1–5 of 43